Astrana Health, Inc. (ASTH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 1.5B 3B 4.5B Q3 '24: 1.7B Q4 '24: 2B Q1 '25: 2.3B Q2 '25: 2.4B Q3 '25: 2.9B Q4 '25: 3.2B Q1 '26: 3.5B Q2 '26: 3.8B Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

0 700K 1.4M 2.1M Q4 '11: 709.1K Q3 '12: 1.5M Q4 '12: 1.3M Q1 '13: 1.5M Q2 '13: 1.7M Q3 '13: 1.5M Q4 '13: 1.8M Q1 '14: 1.4M Q4 '11 Q3 '12 Q4 '12 Q1 '13 Q2 '13 Q3 '13 Q4 '13 Q1 '14

Operating Income TTM

0 35M 70M 105M Q3 '24: 84.8M Q4 '24: 89.3M Q1 '25: 79.8M Q2 '25: 70.1M Q3 '25: 60.9M Q4 '25: 78.5M Q1 '26: 86.5M Q2 '26: 100.5M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

0 25M 50M 75M Q3 '23: 44.6M Q4 '23: 60.7M Q1 '24: 62.4M Q2 '24: 68.4M Q3 '24: 62.5M Q4 '25: 22.5M Q1 '26: 30.2M Q2 '26: 40.5M Q3 '23 Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 1.5B 3B 4.5B Q3 '24: 1.5B Q4 '24: 1.8B Q1 '25: 2B Q2 '25: 2.1B Q3 '25: 2.6B Q4 '25: 2.8B Q1 '26: 3.2B Q2 '26: 3.4B Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

0 60M 120M 180M Q3 '23: 133.9M Q4 '23: 68.2M Q1 '24: 66.5M Q2 '24: 63.9M Q3 '24: 82.4M Q4 '25: 114.6M Q1 '26: 166M Q2 '26: 107.9M Q3 '23 Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

0 60M 120M 180M Q3 '23: 111.5M Q4 '23: 39.7M Q1 '24: 43.6M Q2 '24: 49.5M Q3 '24: 69.9M Q4 '25: 104.5M Q1 '26: 155M Q2 '26: 94.4M Q3 '23 Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '24: 47.7M Q2 '24: 48M Q3 '24: 48.2M Q1 '25: 48.9M Q2 '25: 49.5M Q3 '25: 49.5M Q1 '26: 49.1M Q2 '26: 49.8M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 0.50 1.00 1.50 Q3 '23: 0.95 Q4 '23: 1.29 Q1 '24: 1.32 Q2 '24: 1.44 Q3 '24: 1.30 Q4 '25: 0.47 Q1 '26: 0.62 Q2 '26: 0.83 Q3 '23 Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.